Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-66.67	4.64	13.91
Graham Fair Price	41.43	0.49	0.34
PEG	-58.82	-0.13	0.32
Price/Book	-4.94	0.28	0.29
Price/Cash Flow	29.51	-8.54	-12.11
Prices/Earnings	52.47	-12.78	-26.89
Price/Sales	-52.47	0.46	0.96
Price/FCF	29.51	-8.54	-12.11
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	3.03	0.18	0.17
Operating Margin	301.10	< 0.005	< 0.005
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-100.00
ROIC	< 0.005	< 0.005	381.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.15	0.21	-29.98
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.03	7.02	581.23
EPS QOQ	0.84	-0.97	15.42
FCF QOQ	-1.46	-0.35	76.08
Revenue QOQ	-0.29	1.00	240.41
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	46.43	23.36	-49.68
Days Sales Outstanding (DSO)	103.21	52.61	-49.02
Inventory Turnover	1.94	3.85	98.72
Debt/Capitalization	0.07	0.08	14.66
Quick Ratio	1.57	1.59	1.64
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.39	1.39	< 0.005
Cash	0.22	0.22	0.96
Capex	-0.03	-0.05	-50.08
Free Cash Flow	-0.03	-0.05	-34.87
Revenue	0.42	0.84	100.01
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.10	2.10	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.60	-1.71	69.55
Naive Interpretation	Member

06 - Financial Health · Bad

Rating